DiscoverExecutive Insights for Life Sciences InnovatorsSaurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics
Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics

Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics

Update: 2025-09-08
Share

Description

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Saurabh Johri, Chief Business Officer at Catena Biosciences, a pioneering company revolutionizing protein conjugation technologies for next-generation therapeutics. Saurabh shares insights on Catena’s platform, its potential to reshape therapeutic development, and the company’s vision for advancing precision medicine through novel protein engineering approaches.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on June 6, 2025.

Comments 
loading
In Channel
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics

Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics

GeneCoda® Executive Search